Vorasidenib
(asked on 4th September 2023) - View Source
Question to the Department of Health and Social Care:
To ask His Majesty's Government what assessment they have made of the efficacy of Vorasidenib for the treatment of brain tumours.
This question was answered on 7th September 2023
In the United Kingdom, medicines need to have a licence before they can be marketed, and these are granted by the Medicines and Healthcare products Regulatory Agency (MHRA). The MHRA has not issued a scientific opinion for Vorasidenib. Should an application for Vorasidenib be received, the MHRA will consider this accordingly.